← Open Payments lookup

ANN ROY: Open Payments

NPI 1922675537 · SUGAR LAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,862 in 68 payments from 13 companies in 2025. Trend: 2023 $48 · 2024 $1,137 · 2025 $1,862

Food & beverage: $1,862
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP12$570
Novo Nordisk Inc10$287
Bayer Healthcare Pharmaceuticals Inc.11$209
Merck Sharp & Dohme LLC8$164
Lilly USA, LLC4$140
Sumitomo Pharma America, Inc.6$129
Corcept Therapeutics6$119
GlaxoSmithKline, LLC.4$105
Xeris Pharmaceuticals, Inc.3$53
CeQur Corporation1$35

Products named: Ozempic, BREZTRI, FARXIGA, Kerendia, JARDIANCE, GEMTESA, VERQUVO, Korlym.

Industry payments across TX — which companies pay providers there.